These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
    Author: Kikuchi K, Umehara T, Nishikawa F, Fukuda K, Hasegawa T, Nishikawa S.
    Journal: Biochem Biophys Res Commun; 2009 Aug 14; 386(1):118-23. PubMed ID: 19501043.
    Abstract:
    Hepatitis C virus (HCV) translation begins within the internal ribosome entry site (IRES). We have previously isolated two RNA aptamers, 2-02 and 3-07, which specifically bind to domain II and domain III-IV of the HCV IRES, respectively, and inhibit IRES-dependent translation. To improve the function of these aptamers, we constructed two conjugated molecules of 2-02 and 3-07. These bound to the target RNA more efficiently than the two parental aptamers. Furthermore, they inhibited IRES-dependent translation about 10 times as efficiently as the 3-07 aptamer. This result indicates that combining aptamers for different target recognition sites potentiates the inhibition activity by enhancing the domain-binding efficiency.
    [Abstract] [Full Text] [Related] [New Search]